Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
1. Lithium Pentanoate
2. N-pentanoic Acid
3. N-pentanoic Acid, 11c-labeled
4. N-pentanoic Acid, 11c-labeled Sodium Salt
5. N-pentanoic Acid, Ammonium Salt
6. N-pentanoic Acid, Maganese (+2) Salt
7. N-pentanoic Acid, Potassium Salt
8. N-pentanoic Acid, Sodium Salt
9. N-pentanoic Acid, Zinc Salt
1. Pentanoic Acid
2. N-valeric Acid
3. 109-52-4
4. N-pentanoic Acid
5. Valerianic Acid
6. 1-butanecarboxylic Acid
7. Propylacetic Acid
8. Butanecarboxylic Acid
9. Pentoic Acid
10. Kyselina Valerova
11. Valeric Acid, N-
12. Valeric Acid, Normal
13. N-pentanoate
14. Kyselina Valerova [czech]
15. Valerate
16. Fema No. 3101
17. Valeriansaeure
18. N-valerate
19. 1-pentanoic Acid
20. Nsc 406833
21. N-c4h9cooh
22. Gzk92pjm7b
23. Ch3-[ch2]3-cooh
24. Chebi:17418
25. Nsc-406833
26. 64118-37-2
27. Ncgc00183281-01
28. C5:0
29. Dsstox_cid_1655
30. Dsstox_rid_76267
31. Dsstox_gsid_21655
32. Valericacid
33. Cas-109-52-4
34. Shf
35. Hsdb 5390
36. Butane-1-carboxylic Acid
37. Einecs 203-677-2
38. Unii-gzk92pjm7b
39. Mfcd00004413
40. Brn 0969454
41. Pentoate
42. Propylacetate
43. Valerianate
44. Valeriansaure
45. Ai3-08657
46. Butanecarboxylate
47. 1-pentanoate
48. 1ylv
49. 1-butanecarboxylate
50. Valeric Acid Normal
51. N-bucooh
52. 1173023-05-6
53. Valeric Acid, 99%
54. Valeric Acid, >=99%
55. Bmse000345
56. Ec 203-677-2
57. Pentanoic Acid Valeric Acid
58. Schembl5886
59. Valeric Acid [fcc]
60. Wln: Qv4
61. Valeric Acid [fhfi]
62. N-valeric Acid [mi]
63. 4-02-00-00868 (beilstein Handbook Reference)
64. Mls001066335
65. Pentanoic Acid [hsdb]
66. Valeric Acid [mart.]
67. Pentanoic Acid (valeric Acid)
68. Chembl268736
69. Gtpl1061
70. Dtxsid7021655
71. Valeric Acid ( Pentanoic Acid )
72. Valeric Acid, Analytical Standard
73. Hms2267a03
74. Valeric Acid-[3,4,5-13c3]
75. Hy-n6056
76. Tox21_113414
77. Tox21_201561
78. Tox21_303030
79. Lmfa01010005
80. Nsc406833
81. Stl169350
82. Valeric Acid, >=99%, Fcc, Fg
83. Zinc31500905
84. Akos000118960
85. Db02406
86. Ncgc00183281-02
87. Ncgc00183281-03
88. Ncgc00256597-01
89. Ncgc00259110-01
90. Bs-42203
91. Smr000471834
92. Cs-0032261
93. Ft-0651620
94. Ft-0694066
95. V0003
96. Valeric Acid, Pharmaceutical Impurity Standard
97. C00803
98. Valproic Acid Impurity A [ep Impurity]
99. Q407796
100. J-002298
101. F2191-0105
102. Z955123768
| Molecular Weight | 102.13 g/mol |
|---|---|
| Molecular Formula | C5H10O2 |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 102.068079557 g/mol |
| Monoisotopic Mass | 102.068079557 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Complexity | 59.1 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
It is metabolized by splitting into acetic acid and pyruvic acid.
Patty, F. (ed.). Industrial Hygiene and Toxicology: Volume II: Toxicology. 2nd ed. New York: Interscience Publishers, 1963., p. 1782
Labeled valeric acid was incubated with mixed culture of cellulolytic rumen bacteria resulting in the labeling of lipids. The distribution of radioactivity indicated that 1-(14)C-labeled valeric acid was not utilized directly for biosynthesis of higher fatty acids with odd number of carbon atoms by the addition of 2 C, but it was probably degraded into 1-(14)C-labeled acetic acid and into propionic acid.
HIDIROGLOU M, LEPAGE M; CAN J BIOCHEM 45 (12): 1789 (1967)
Valeric acid is formed by rumen microorganisms during the metabolism of proline, leucine, isoleucine, norleucine, and several intermediates of carbohydrate metabolism.
Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. 5:713
Valeic acid is rapidly metabolized in rat liver to acetate and propionate, giving rise to both glycogen and ketone bodies. This same route of metabolism also predominates in rumen microorganisms.
Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. 5:714
For more Metabolism/Metabolites (Complete) data for n-PENTANOIC ACID (6 total), please visit the HSDB record page.
... Pentanoate was metabolized to a greater extent than octanoate and did not inhibit growth. Pentanoate inhibited acetate utilization in both the inner mitochondrial and peroxisomal compartments as indicated by a reduction in the incorporation of label from [1-14-C]acetate into lipids and into CO2, but there was no difference in oxidation of [2-14-C]pyruvate when pentanoate was the fatty acid substrate as compared to octanoate. Glyconeogenesis was inhibited when pentanoate was substituted for octanoate. ... The effects of 4-pentenoic acid were essentially the same whether octanoate or pentanoate was the fatty acid substrate, i.e. inhibition of glyconeogenesis from all labeled substrates and inhibition of [2-14-C]pyruvate oxidation.
Raugi GJ; J Biol Chem 250 (11): 4067-72 (1975)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Direct Compression
Thickeners and Stabilizers
Granulation
Parenteral
Taste Masking
Lubricants & Glidants
Co-Processed Excipients
Chewable & Orodispersible Aids
Coating Systems & Additives
Controlled & Modified Release
Disintegrants & Superdisintegrants
Topical
Film Formers & Plasticizers
Rheology Modifiers
Emulsifying Agents
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
37
PharmaCompass offers a list of Valeric Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Valeric Acid manufacturer or Valeric Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valeric Acid manufacturer or Valeric Acid supplier.
PharmaCompass also assists you with knowing the Valeric Acid API Price utilized in the formulation of products. Valeric Acid API Price is not always fixed or binding as the Valeric Acid Price is obtained through a variety of data sources. The Valeric Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A n-Valeric acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of n-Valeric acid, including repackagers and relabelers. The FDA regulates n-Valeric acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. n-Valeric acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A n-Valeric acid supplier is an individual or a company that provides n-Valeric acid active pharmaceutical ingredient (API) or n-Valeric acid finished formulations upon request. The n-Valeric acid suppliers may include n-Valeric acid API manufacturers, exporters, distributors and traders.
click here to find a list of n-Valeric acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A n-Valeric acid CEP of the European Pharmacopoeia monograph is often referred to as a n-Valeric acid Certificate of Suitability (COS). The purpose of a n-Valeric acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of n-Valeric acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of n-Valeric acid to their clients by showing that a n-Valeric acid CEP has been issued for it. The manufacturer submits a n-Valeric acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a n-Valeric acid CEP holder for the record. Additionally, the data presented in the n-Valeric acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the n-Valeric acid DMF.
A n-Valeric acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. n-Valeric acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of n-Valeric acid suppliers with CEP (COS) on PharmaCompass.
n-Valeric acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of n-Valeric acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right n-Valeric acid GMP manufacturer or n-Valeric acid GMP API supplier for your needs.
A n-Valeric acid CoA (Certificate of Analysis) is a formal document that attests to n-Valeric acid's compliance with n-Valeric acid specifications and serves as a tool for batch-level quality control.
n-Valeric acid CoA mostly includes findings from lab analyses of a specific batch. For each n-Valeric acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
n-Valeric acid may be tested according to a variety of international standards, such as European Pharmacopoeia (n-Valeric acid EP), n-Valeric acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (n-Valeric acid USP).
